HALO Short Information Halozyme Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	3,388,406
Total Actual Volume	24,853,914

Averages
Average Short Volume	169,420
Average Short Percentage	61.93%

Is there a HALO Short Squeeze or Breakout about to happen?

See the HALO Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-09-27	39.07	38.64	39.53	38.23	1,012,333	127,594	75.6104
2022-09-26	38.65	38.58	39.11	38.25	887,610	120,983	66.2391
2022-09-23	38.37	38.82	38.88	38.03	881,733	66,511	54.3764
2022-09-22	38.83	38.74	39.215	38.22	1,078,633	82,827	29.6592
2022-09-21	40.32	39.21	40.57	39.11	825,685	118,935	68.9974
2022-09-20	40.5	40.28	40.98	39.65	2,354,066	269,419	40.9006
2022-09-19	41.46	40.91	41.96	39.935	2,805,237	392,597	56.0451
2022-09-16	42.21	41.97	42.79	41.38	2,655,559	150,690	69.6977
2022-09-15	42.34	42.33	42.91	41.81	906,959	135,439	70.5625
2022-09-14	41.46	42.51	42.67	41.22	1,170,410	225,701	78.0160
2022-09-13	40.94	41.3	41.55	40.01	1,493,531	212,014	68.9019
2022-09-12	41.4	42	42.01	41.21	858,168	103,405	51.6839
2022-09-09	40.6	41.4	41.58	40.32	866,690	112,481	57.5312
2022-09-08	39	39.67	39.67	38.4	795,590	87,994	54.9310
2022-09-07	38.39	39.41	39.52	38.35	1,000,752	252,681	74.5235
2022-09-06	38.685	38.53	39.12	38.26	1,060,442	221,572	65.2333
2022-09-01	40.46	40.58	40.66	39.44	956,864	108,472	34.0999
2022-08-31	40.89	40.73	41.15	40.42	1,179,357	285,779	84.3115
2022-08-30	40.84	40.73	40.98	40.35	955,119	170,620	68.9934
2022-08-29	39.94	40.53	40.96	39.57	1,109,176	142,692	68.3123

Stock Information

Halozyme Therapeutics Inc. Company Name:

HALO Stock Symbol:

NASDAQ Market:

Halozyme Therapeutics Inc. Logo

Get HALO Alerts

News, Short Squeeze, Breakout and More Instantly...

HALO - Halozyme to Participate in the 2022 Wells Fargo Healthcare Conference

Halozyme to Participate in the 2022 Wells Fargo Healthcare Conference PR Newswire SAN DIEGO , Sept. 1, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley , president and chief executive o...
HALO - Halo Shores Up Losses As Revenues Rise

Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) posted mostly positive results with revenues ticking up over the quarter — illustrating the west-coast operator’s pursuit to shave losses and pay down debt. The company announced its financial results for the first ...
HALO - Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028

Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028 PR Newswire SAN DIEGO , Aug. 15, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"...